Evelo Biosciences, Inc. EVLO
Set alert
0.00 USD 0.00 0.00%
At close · Oct 29
0.0005 Day range 0.0005
0.0001 52-week range 0.0005
- YTD
- -80.00%
- 1 year
- -80.00%
- Open
- 0.0005
- Prev close
- 0.0001
- Mkt cap
- 1.90K
- Vol
- 133
- Avg vol
- 2.65K
- EPS
- -3.14
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.0005
- High
- 0.0005
- Forward P/E
- -0.03
- Beta
- 1.89
- Short ratio
- 0.12
- Inst. own
- 83.03%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Dec 26, 2024
- 50-d avg
- 0.26256
- 200-d avg
- 3.43
- 1y target
- 10.00
Financial health
Altman Z-Score
-53.28 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
3 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
Valuation
P/E -1.2×
FY 2016 5y median -2.6× FY 2022
P/S 0.0×
FY 2016 5y median 0.0× FY 2022
P/B -28.1×
FY 2016 5y median 2.2× FY 2022
P/FCF -1.4×
FY 2016 5y median -3.3× FY 2022
EV/EBITDA -1.3×
FY 2016 5y median -2.7× FY 2022
EV/Sales 0.0×
FY 2016 5y median 0.0× FY 2022
FCF Yield -72.6%
FY 2016 5y median -30.6% FY 2022
Profitability
Gross Margin 0.0%
FY 2016 5y median 0.0% FY 2022
Operating Margin 0.0%
FY 2016 5y median 0.0% FY 2022
Net Margin 0.0%
FY 2016 5y median 0.0% FY 2022
ROE 2294.2%
FY 2016 5y median -142.3% FY 2022
ROIC -199.7%
FY 2016 5y median -126.0% FY 2022
ROA -177.7%
FY 2016 5y median -103.3% FY 2022
Growth (YoY)
Revenue 0.0%
FY 2016 FY 2022
Operating Income 6.0%
FY 2016 FY 2022
EPS (diluted) 43.1%
FY 2016 FY 2022
Free Cash Flow -3.7%
FY 2016 FY 2022
Financial Health
Current Ratio 4.2×
FY 2016 5y median 4.2× FY 2022
Quick Ratio 4.2×
FY 2016 5y median 4.2× FY 2022
Debt / Equity -10.2×
FY 2016 5y median 0.3× FY 2022
Net Debt / EBITDA -0.0×
FY 2016 5y median 0.3× FY 2022
Interest Coverage -23.2×
FY 2016 5y median -37.2× FY 2022
Dividends
Dividend Yield 0.0%
FY 2016 5y median 0.0% FY 2022
Payout Ratio 0.0%
FY 2016 5y median 0.0% FY 2022
Annual · latest fiscal year ends 2022-12-31